FDA issued a final guidance document entitled “Dosage and Administration Section of Labeling for Human Prescription Drug and Biological Products–Content and Format.” The guidance identifies information that should be included in the labeling portion of a marketing application to ensure language that is clear and accessible. The guidance recommends the format for organizing information and criteria to determine when and how to include information from other labeling sections.
